Adapthealth (AHCO) Stock
Home medical equipment specialist for respiratory and chronic care. Here's the price, business snapshot, and what's worth knowing about Adapthealth in August 2026.
AdaptHealth Corp (AHCO) is a US-based provider of home medical equipment and related services, specialising in respiratory and chronic-care therapies delivered in patients’ homes. With a market capitalisation of about $1.3 billion, the business benefits from structural trends such as an ageing population and a healthcare shift towards lower-cost, home-based care. Key considerations for investors include exposure to reimbursement and regulatory changes, integration of acquisitions, operational complexity and margin sensitivity to supply and labour costs. Performance can be cyclical and values can rise or fall; past results do not guarantee future returns. This summary is for general educational purposes only and is not personal financial advice — suitability depends on your objectives, risk tolerance and time horizon. Investors should read company filings and consider speaking to a qualified adviser before making decisions.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying AdaptHealth's stock, anticipating significant growth potential ahead.
Financial Health
AdaptHealth is generating steady revenue and cash flow, but profitability could be improved.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Homecare market tailwinds
Ageing populations and a move towards care at home can support demand, though revenue growth is subject to reimbursement and operational execution.
Services and scale
A mix of equipment sales and recurring services can provide stable cash flows if operations scale efficiently, but acquisition integration can affect margins.
Regulation & reimbursement
Payment policies and regulation materially affect profitability, so investors should monitor policy changes and payer relationships.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
